Inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when Mae, a beloved Grandmother, was prescribed oxygen therapy. Inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. We estimate that more than 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy. Our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. We believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. With each step we take to improve our products and service, our customers take another step toward more freedom.
Company Growth (employees)
Type
Public
HQ
Goleta, US
Size (employees)
602 (est)+11%
Website
inogen.com
Inogen is headquartered in Goleta, US

Key People at Inogen

Raymond Huggenberger

Raymond Huggenberger

CEO

Inogen Office Locations

Inogen has offices in Goleta, Ventura, Santa Barbara, Aurora and in 11 other locations
Goleta, US (HQ)
326 Bollay Dr

Inogen Data and Metrics

Inogen Financial Metrics

Inogen's revenue was reported to be $202.8 m in FY, 2016 which is a 28% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

202.8 m

Revenue growth (FY, 2015 - FY, 2016), %

28%

Net income (FY, 2016)

20.5 m

Market capitalization (26-May-2017)

1.8 b

Closing share price (26-May-2017)

89

Cash (31-Dec-2016)

92.9 m
Inogen's current market capitalization is $1.8 b.
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Revenue

112.5 m159 m202.8 m

Revenue growth, %

41%28%

Cost of goods sold

57 m82.7 m

Gross profit

55.5 m76.3 m

Gross profit Margin, %

49%48%

Sales and marketing expense

24.1 m31.4 m

R&D expense

3 m4.2 m

General and administrative expense

17.9 m25.7 m

Operating expense total

45 m61.2 m

EBIT

10.5 m15.1 m

EBIT margin, %

9%9%

Interest expense

(449 k)(22 k)

Interest income

42 k102 k

Pre tax profit

10.1 m

Income tax expense

3.2 m3.1 m

Net Income

6.8 m11.6 m20.5 m
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Cash

56.8 m66.1 m92.9 m

Accounts Receivable

30.8 m

Inventories

1.1 m870 k1.7 m

Current Assets

92.5 m114.8 m161.5 m

PP&E

31.9 m30.7 m25.2 m

Total Assets

140.1 m161.3 m214 m

Accounts Payable

11.3 m12.9 m12.8 m

Total Debt

614 k

Current Liabilities

18.7 m22 m22.8 m

Additional Paid-in Capital

174.8 m179.1 m194.5 m

Retained Earnings

(56.7 m)(45.1 m)(12.4 m)

Total Equity

118.2 m134 m182.1 m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

1.2 x1.2 x1.2 x
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Net Income

6.8 m11.6 m20.5 m

Depreciation and Amortization

12.1 m14 m13.6 m

Accounts Receivable

(22.2 m)(16.7 m)(32.7 m)

Inventories

(3.6 m)(2.6 m)(7.5 m)

Accounts Payable

3.6 m1.6 m(86 k)

Cash From Operating Activities

15.7 m38.2 m31 m

Purchases of PP&E

(1.6 m)(2.2 m)

Cash From Investing Activities

(16.3 m)(29.3 m)(11.9 m)

Cash From Financing Activities

43.9 m381 k7.7 m

Interest Paid

487 k26 k10 k

Income Taxes Paid

2.1 m
Y, 2016

Financial Leverage

1.2 x

Inogen Market Value History

Inogen Job Categories

Inogen Online and Social Media Presence

Inogen Company Life and Culture

You may also be interested in